Advertisement Akorn's CEO to leave - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Akorn’s CEO to leave

Akorn, a manufacturer of sterile specialty pharmaceuticals, has announced that its president and CEO, Arthur Przybyl, is leaving the company and that, pending selection of a new president and CEO, a committee of three board members will oversee operations of the company and identify Mr Przybyl's replacement.

The committee consists of John Kapoor, chairman of the board of directors and directors Randall Wall and Jerry Ellis.

Dr Kapoor said: “Our current management team will execute the strategy for the company to achieve continued growth and success. We will endeavor to identify a replacement as soon as practicable.”